Biosino Bio-Technology and Science Incorporation (HKG:8247) Shares Fly 68% But Investors Aren't Buying For Growth
Biosino Bio-Technology and Science Incorporation (HKG:8247) shareholders would be excited to see that the share price has had a great month, posting a 68% gain and recovering from prior weakness. U
Simply Wall St19:35 ET
Zhongsheng Beikong Biotechnology (08247.HK): Li Jifeng Resigns as Shareholder Representative Supervisor and Chairman of the Supervisory Board
Gelonghui, April 26, 丨 Zhongsheng Beikong Biotechnology (08247.HK) announced that on April 26, 2024, Li Jifeng has resigned as the representative supervisor of the company's shareholders and the chairman of the company's board of supervisors due to other work arrangements.
Gelonghui FinanceApr 26 04:55 ET
Zhongsheng Beikong Biotechnology (08247) announced its 2023 annual results. Shareholders should account for a loss of 11.648 million yuan
Zhongsheng Beikong Biotechnology (08247) announced its annual results for the year ended December 31, 2023, with revenue reaching...
Zhitong FinanceMar 27 19:31 ET
BIOSINO BIO-TEC: Annual Report 2023
Futu NewsMar 27 18:18 ET · Announcements
BIOSINO BIO-TEC: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2023
Futu NewsMar 27 18:14 ET · Announcements
Zhongsheng Beijing Holdings Biotechnology (08247) issued a profit warning. The net loss for the year is expected to increase from 18 million yuan to 22 million yuan over the same period last year
According to the Zhitong Finance App, Zhongsheng Beijing Holdings Biotechnology (08247) issued an announcement. It is expected that the Group will have a net loss of RMB 18 million to RMB 22 million for the year ended December 31, 2023, while net profit of about RMB 14.202 million for the year ended December 31, 2022. According to the announcement, the expected losses during the reporting period were mainly due to changes in domestic and foreign public health prevention and control policies, a decline in market demand; and a decrease in the Group's gross profit due to falling product prices due to centralized procurement in the industry; and the Group's superior products (such as flow cytometry and
Zhitong FinanceMar 18 06:43 ET
BIOSINO BIO-TEC: PROFIT WARNING
Futu NewsMar 18 06:41 ET · Announcements
Little Excitement Around Biosino Bio-Technology and Science Incorporation's (HKG:8247) Revenues As Shares Take 31% Pounding
To the annoyance of some shareholders, Biosino Bio-Technology and Science Incorporation (HKG:8247) shares are down a considerable 31% in the last month, which continues a horrid run for the company.
Simply Wall StFeb 8 17:04 ET
Zhongsheng Beikong Biotechnology (08247) released the first three quarter results, and shareholders accounted for losses of 5.993 million yuan
According to the Zhitong Finance App, Zhongsheng Beikong Biotechnology (08247) released results for the nine months ended September 30, 2023, with operating income of 2106 million yuan (RMB, same below), a year-on-year decrease of 23.6%; parent company owners accounted for losses of 5.993 million yuan, profit for the same period last year; basic loss of 0.041 yuan per share. During the reporting period, the company completed a total of 42 types of II products, including the glycated serum protein assay kit (NBT method), and 7 Class III products, including the herpes simplex virus type 1 IgG antibody test kit (chemiluminescence method), were changed and registered. α-L-
Zhitong FinanceNov 14, 2023 07:28 ET
BIOSINO BIO-TEC: Third Quarterly Report 2023
Futu NewsNov 14, 2023 07:25 ET · Announcements
BIOSINO BIO-TEC: THIRD QUARTERLY RESULTS ANNOUNCEMENT FOR THE THREE MONTHS AND NINE MONTHS ENDED 30 SEPTEMBER 2023
Futu NewsNov 14, 2023 07:24 ET · Announcements
Zhongsheng Beikong Biotechnology (08247): Yang Peng appointed as non-executive director and vice chairman
Zhongsheng Beikong Biotechnology (08247) announced that Mr. Yang Peng has been appointed as the company's non-executive director and vice chairman,...
Zhitong FinanceSep 26, 2023 09:27 ET
BIOSINO BIO-TEC: Interim Report 2023
Futu NewsAug 10, 2023 08:55 ET · Announcements
BIOSINO BIO-TEC: INTERIM RESULTS ANNOUNCEMENT FOR THE THREE MONTHS AND SIX MONTHS ENDED 30 JUNE 2023
Futu NewsAug 10, 2023 08:53 ET · Announcements
Risks Still Elevated At These Prices As Biosino Bio-Technology and Science Incorporation (HKG:8247) Shares Dive 38%
Biosino Bio-Technology and Science Incorporation (HKG:8247) shareholders that were waiting for something to happen have been dealt a blow with a 38% share price drop in the last month. For any long-term shareholders, the last month ends a year to forget by locking in a 53% share price decline.
Simply Wall StJul 31, 2023 18:12 ET
BIOSINO BIO-TEC: NOTICE OF BOARD MEETING
Futu NewsJul 28, 2023 07:31 ET · Announcements
Zhongsheng Beikong Biotechnology (08247) plans to appoint Yang Peng as a non-executive director and company vice chairman to replace Sun Zhe
According to the Zhitong Finance App, Zhongsheng Beikong Biotechnology (08247) announced that Yang Peng was recommended by the Institute of Biophysics of the Chinese Academy of Sciences, the main shareholder of the company, and nominated by the company's nomination committee as a candidate for non-executive director and vice chairman of the company to replace Sun Zhe, the company's current non-executive director and vice chairman. The nomination will be submitted to the company's next shareholders' meeting for consideration.
Zhitong FinanceJul 24, 2023 10:18 ET
BIOSINO BIO-TEC: First Quarterly Report 2023
moomoo NewsMay 12, 2023 09:18 ET · Announcements
BIOSINO BIO-TEC: FIRST QUARTERLY RESULTS ANNOUNCEMENT FOR THE THREE MONTHS ENDED 31 MARCH 2023
moomoo NewsMay 12, 2023 09:13 ET · Announcements
Zhongsheng Beikong Biotechnology: Annual Report 2022
moomoo NewsMar 31, 2023 10:55 ET · Announcements
No Data
No Data